Midterm Results of Robotic versus Single-port Thoracoscopic Lobectomy in Non Small Cell Lung Cancer: Propensity Score Matched Analysis
Kook Nam Han, Jeong In Hong, Hyun Koo Kim, Young Ho Choi
Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea
Purpose : Robotic lobectomy has been one of the surgical options for patients who able to tolerate conventional lobectomy with improved postoperative outcomes compared with thoracotomy and VATS. However, the benefit of robotic lobectomy compared to VATS is still under debate. This study aims to compare the perioperative, oncologic outcomes of robotic lobectomy versus single-port thoracoscopic lobectomy.
Methods : Between January March 2012 to April 2020, 618 patients underwent 137 robotic and 481 single-port VATS anatomic resection in a single institution. We compared the perioperative outcome, Long-term survival, recurrences, and postoperative pain in propensity-score matched groups who performed more than segmentectomy for non-small cell lung cancer as curative intent.
Results : In matched groups, the mean operation time was 208.18 ± 58.01 minutes in the robotic group and 166.61 ± 52.46 minutes in the single-port VATS group (p<0.001). The total medical cost was significantly higher in the robotic lobectomy group (p<0.001). Conversion to multi-port or open thoracotomy (p=1.000), the number of mediastinal lymph node dissection (p=0.379), and perioperative morbidity (p=0.583) were not different between groups. Postoperative hospital stays and chest tube indwelling time were shorter in the robotic lobectomy group (p=0.004). In a propensity score-matched group, the overall survival (p=0.440) and recurrence-free survival (p=0.94) were not significantly different.
Conclusion : In a single-institution study, robotic lobectomy showed longer operation time, shorter hospital stay and chest tube indwelling times, and similar oncologic outcomes compared to single-port thoracoscopic lobectomy in lung cancer.
책임저자: Hyun Koo Kim
Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea
발표자: Kook Nam Han, E-mail : hdoc@korea.ac.kr